Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-13-013190)

Filing Details

Accession Number:: 0001179110-13-013190
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-08-15 16:46:51
Reporting Period:: 2013-08-14

Filing Date:: 2013-08-15
Accepted Time:: 2013-08-15 16:46:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884629	Actavis Inc.	ACT	Pharmaceutical Preparations (2834)	953872914

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242066	Todd R Joyce	Morris Corporate Center Iii, 400 Interpace Parkway Parsippany NJ 07054	Cfo-Global	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0033	Disposition	2013-08-14	11,000	$137.85	84,470	No	4	S	Direct
Common Stock, Par Value $0.0033	Disposition	2013-08-14	4,000	$138.35	80,470	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.0033	3,283	Indirect	Trust

Footnotes

Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Actavis, Inc., as amended.